Activation of the TLR4/MyD88 signaling pathway contributes to the development of human hepatocellular carcinoma via upregulation of IL-23 and IL-17A

por Kang, Yuming, Su, Guoai, Sun, Jianmin, Zhang, Yanli
Publicado 2018

P1168: DURABLE REMISSION AFTER SEQUENTIAL CD19/20 CAR T-CELL “CAKE-ICING” THERAPY OCCURRED IN REFRACTORY/RELAPSED DLBCL

por Zheng, Peihao, Xue, Fei, Yang, Fan, Feng, Shaomei, Guo, Yuelu, Shi, Hui, Su, Guoai, MA, Lixia, Rui, Liu, Deng, Biping, Hu, Kai, Ke, Xiaoyan
Publicado 2023

PB2326: OUTCOMES OF ANTI-CANCER THERAPY IN PATIENTS WITH PROGRESSIVE REFRACTORY/RELAPSED B-CELL LYMPHOMA DURING SEVERE CORONAVIRUS DISEASE 2019 (COVID-19): A REAL-WORLD STUDY FROM...

por Su, Guoai, Hu, Kai, Ke, Xiaoyan, Shi, Hui, Zheng, Peihao, Yang, Fan, Feng, Shaomei, Guo, Yuelu, MA, Liaxia, Xue, Fei, Rui, Liu, Xu, Teng, Fu, Zhonghua, Deng, Biping
Publicado 2023